6.6
93.2 %
87.9 %
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Overall Web of Science coverage for peer reviewed publications in this unit is good, 93.2%.
Note that the coverage numbers for Web of Science and Scopus apply to publications in the KTH bibliometric database Bibmet. If a WoS-id or Scoupus-id from DiVA can not be matched in Bibmet, it does not count as covered.
The bibliometric indicators referred are based on publications registered in DiVA. Only publications from currently employed researchers at KTH are included. The rolling nature of this report means that it provides more of a current overview and less of a historic stable trend, since it excludes publications written by researchers that are no longer affiliated to KTH, but have been at some point in time.
Indicators in the Citation impact, Journal impact and Co‑publishing tabs are based on Web of Science publications only. Corresponding Scopus indicators can be found under the Scopus tab.
Publication data is available only after login.
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 4.7 | 2.6 | 6.0 | 4.8 | 4.0 | 5.7 | 3.9 | 31.8 | 93.2% | 0.9 |
| Article, other | 2.5 | 1.8 | 0.2 | 2.1 | 1.0 | 1.3 | 2.1 | 11.1 | 100.0% | 0.2 |
| Conference paper, other | 0.2 | NA | NA | 0.2 | 0.1 | NA | NA | 0.6 | 0.0% | 0.0 |
| Chapter in book | NA | NA | NA | 0.3 | 0.5 | NA | 0.7 | 1.5 | 22.5% | 0.8 |
| Doctoral thesis | NA | 1.0 | NA | NA | NA | NA | NA | 1.0 | 0.0% | 0.0 |
| DiVA publication type | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | Publications | WoS coverage | Scopus coverage |
|---|---|---|---|---|---|---|---|---|---|---|
| Article, peer review | 20 | 12 | 25 | 15 | 16 | 24 | 15 | 127 | 96.9% | 1 |
| Article, other | 8 | 3 | 1 | 10 | 5 | 7 | 7 | 41 | 100.0% | 0 |
| Conference paper, other | 1 | NA | NA | 1 | 1 | NA | NA | 3 | 0.0% | 0 |
| Chapter in book | NA | NA | NA | 1 | 1 | NA | 2 | 4 | 25.0% | 1 |
| Doctoral thesis | NA | 1 | NA | NA | NA | NA | NA | 1 | 0.0% | 0 |
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 4.6 | 13.5 | 3.0 | 0.3 | 7.3% |
| 2015 | 3.0 | 13.4 | 4.4 | 0.0 | 0.0% |
| 2016 | 3.5 | 17.8 | 5.0 | 0.3 | 9.4% |
| 2017 | 4.8 | 38.2 | 8.0 | 0.6 | 12.1% |
| 2018 | 2.5 | 12.0 | 4.8 | 0.0 | 0.0% |
| Total | 18.5 | 95.0 | 5.1 | 1.2 | 6.8% |
| Publication years | Publications | Average Cf | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 11.1 | 0.63 | 0.0 | 0.0% |
| 2015-2017 | 11.4 | 0.73 | 0.8 | 7.3% |
| 2016-2018 | 10.9 | 0.78 | 0.9 | 8.4% |
| 2017-2019 | 13.0 | 0.74 | 1.0 | 8.0% |
| Total | 24.2 | 0.69 | 1.0 | 4.3% |
This table is based on Web of Science publication types Article, Proceedings paper, Review, Letter and Editorial.
Rows are based on at least 12 (full counted) publications with moderate Web of Science coverage (at least 62.7%).
(DiVA publication types Article, peer review and Conference paper, peer review)
Indicators based on < 50 publications are considered unreliable
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 52 (full counted) publications with good Web of Science coverage (at least 89.7%).
(DiVA publication type Article, peer review)
| Publication years | Publications | Average Journal Cf | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 11.1 | 1.09 | 3.1 | 28.0% |
| 2015-2017 | 11.4 | 1.01 | 3.0 | 26.1% |
| 2016-2018 | 10.9 | 1.10 | 3.6 | 32.8% |
| 2017-2019 | 13.0 | 1.07 | 3.0 | 22.9% |
| 2018-2020 | 12.1 | 1.07 | 2.3 | 18.6% |
| Total | 28.1 | 1.06 | 6.4 | 22.9% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 52 (full counted) publications with good Web of Science coverage (at least 89%).
(DiVA publication type Article, peer review)
| Publication years | Publications | Swedish non-university co-publications | Share Swedish non-university | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 47 | 16 | 34.0% | 10 | 21.3% |
| 2015-2017 | 43 | 11 | 25.6% | 12 | 27.9% |
| 2016-2018 | 47 | 12 | 25.5% | 15 | 31.9% |
| 2017-2019 | 53 | 9 | 17.0% | 18 | 34.0% |
| 2018-2020 | 53 | 11 | 20.8% | 24 | 45.3% |
| Total | 115 | 30 | 26.1% | 39 | 33.9% |
This table is based on Web of Science publication types Article and Review.
Rows are based on at least 43 (full counted) publications with good Web of Science coverage (at least 96.4%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|
| Russian Federation | 16 | 10 | 6 | 0 | 0 | 3.2 |
| United States | 8 | 2 | 6 | 0 | 0 | 1.3 |
| Japan | 4 | 4 | 0 | 0 | 0 | 1.1 |
| Canada | 3 | 3 | 0 | 0 | 0 | 1.0 |
| Netherlands | 6 | 1 | 5 | 0 | 0 | 0.9 |
| Germany | 4 | 1 | 3 | 0 | 0 | 0.7 |
| United Kingdom | 5 | 1 | 4 | 0 | 0 | 0.6 |
| Switzerland | 3 | 2 | 1 | 0 | 0 | 0.5 |
| Australia | 3 | 1 | 2 | 0 | 0 | 0.5 |
| Denmark | 3 | 2 | 1 | 0 | 0 | 0.4 |
| Singapore | 3 | 1 | 2 | 0 | 0 | 0.4 |
| Oman | 2 | 2 | 0 | 0 | 0 | 0.4 |
| France | 3 | 1 | 2 | 0 | 0 | 0.3 |
| Finland | 3 | 1 | 2 | 0 | 0 | 0.3 |
| Italy | 3 | 0 | 3 | 0 | 0 | 0.3 |
| Saudi Arabia | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Estonia | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Norway | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Austria | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Iran, Islamic Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Israel | 1 | 0 | 1 | 0 | 0 | 0.1 |
| India | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Belgium | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Organization | Organization type | Country | Publications | 1-10 auth | 11-50 auth | 51-200 auth | Over 200 auth | Publications (frac) |
|---|---|---|---|---|---|---|---|---|
| Uppsala University | University | Sweden | 106 | 82 | 24 | 0 | 0 | 22.9 |
| Affibody AB | Company | Sweden | 16 | 11 | 5 | 0 | 0 | 4.2 |
| Tomsk Polytechnic University | University | Russian Federation | 11 | 8 | 3 | 0 | 0 | 2.7 |
| Karolinska Institutet | University | Sweden | 18 | 8 | 10 | 0 | 0 | 2.4 |
| Swedish University of Agricultural Sciences | University | Sweden | 4 | 3 | 1 | 0 | 0 | 1.4 |
| University of Toronto | University | Canada | 3 | 3 | 0 | 0 | 0 | 1.0 |
| Lund University | University | Sweden | 5 | 3 | 2 | 0 | 0 | 0.9 |
| Uppsala University Hospital | University Hospital | Sweden | 6 | 4 | 2 | 0 | 0 | 0.9 |
| Stockholm University | University | Sweden | 3 | 2 | 1 | 0 | 0 | 0.9 |
| Albanova University Centre | University Other | Sweden | 3 | 3 | 0 | 0 | 0 | 0.9 |
| Dept Med Chem | NA | Sweden | 4 | 4 | 0 | 0 | 0 | 0.8 |
| Karolinska University Hospital | University Hospital | Sweden | 7 | 1 | 6 | 0 | 0 | 0.8 |
| Div Mol Imaging | NA | Sweden | 3 | 3 | 0 | 0 | 0 | 0.7 |
| Hyogo College of Medicine | University | Japan | 2 | 2 | 0 | 0 | 0 | 0.7 |
| New York University | University | United States | 2 | 1 | 1 | 0 | 0 | 0.5 |
| National Research Nuclear University MEPhI | University | Russian Federation | 5 | 1 | 4 | 0 | 0 | 0.4 |
| Russian Academy of Sciences | Other Public | Russian Federation | 5 | 0 | 5 | 0 | 0 | 0.4 |
| University of Melbourne | University | Australia | 2 | 1 | 1 | 0 | 0 | 0.4 |
| University of Tübingen | University | Germany | 1 | 1 | 0 | 0 | 0 | 0.4 |
| Nanyang Technological University | University | Singapore | 3 | 1 | 2 | 0 | 0 | 0.4 |
| Erasmus MC | NA | Netherlands | 2 | 1 | 1 | 0 | 0 | 0.4 |
| Sultan Qaboos University | University | Oman | 2 | 2 | 0 | 0 | 0 | 0.4 |
| Radboud University Nijmegen | University | Netherlands | 2 | 0 | 2 | 0 | 0 | 0.3 |
| Rensselaer Polytechnic Institute | University | United States | 1 | 1 | 0 | 0 | 0 | 0.3 |
| NYU Langone Hlth | NA | United States | 1 | 1 | 0 | 0 | 0 | 0.3 |
| Paul Scherrer Institute | Institute | Switzerland | 2 | 1 | 1 | 0 | 0 | 0.3 |
| Odense University Hospitals | University Hospital | Denmark | 2 | 1 | 1 | 0 | 0 | 0.3 |
| RISE - Research Institutes of Sweden | Institute | Sweden | 2 | 2 | 0 | 0 | 0 | 0.3 |
| University of Liverpool | University | United Kingdom | 2 | 0 | 2 | 0 | 0 | 0.3 |
| University of York | University | United Kingdom | 2 | 0 | 2 | 0 | 0 | 0.3 |
| Paul Scherrer Villigen PSI | NA | Switzerland | 1 | 1 | 0 | 0 | 0 | 0.2 |
| King Abdulaziz University (KAU) | University | Saudi Arabia | 1 | 0 | 1 | 0 | 0 | 0.2 |
| Dept Clin Sci | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| ETH Zurich | University | Switzerland | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Inst Immunol Genet & Pathol | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Lab Adv Nucl Energy | NA | Japan | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Tokyo Institute of Technology | University | Japan | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Sahlgrenska University Hospital | University Hospital | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University College London | University | United Kingdom | 1 | 1 | 0 | 0 | 0 | 0.2 |
| University of Gothenburg | University | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Nova Southeastern University (NSU) | University | United States | 2 | 0 | 2 | 0 | 0 | 0.2 |
| University of Milan | University | Italy | 2 | 0 | 2 | 0 | 0 | 0.2 |
| Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry | Institute | Russian Federation | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Abo Akademi University | University | Finland | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Turku University Hospital | University Hospital | Finland | 2 | 1 | 1 | 0 | 0 | 0.2 |
| University of Turku | University | Finland | 2 | 1 | 1 | 0 | 0 | 0.2 |
| Algeta ASA | Company | Norway | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Linnaeus University | University | Sweden | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Lomonosov Moscow State University | University | Russian Federation | 1 | 1 | 0 | 0 | 0 | 0.2 |
| Tagworks Pharmaceuticals | Company | Netherlands | 2 | 0 | 2 | 0 | 0 | 0.2 |
| University of Pittsburgh | University | United States | 2 | 0 | 2 | 0 | 0 | 0.1 |
| Dept Prot Sci | NA | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Tallinn University (TU) | University | Estonia | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Technical University of Denmark (DTU) | University | Denmark | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Jacobs University Bremen (JU) | Institute | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Ridgeview Instruments AB | Company | Sweden | 1 | 1 | 0 | 0 | 0 | 0.1 |
| University of Lyon | University | France | 1 | 1 | 0 | 0 | 0 | 0.1 |
| Innsbruck Medical University | University | Austria | 1 | 1 | 0 | 0 | 0 | 0.1 |
| European Synchrotron Radiation Facility (ESRF) | Institute | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Ferdowsi University of Mashhad | University | Iran, Islamic Republic of | 1 | 0 | 1 | 0 | 0 | 0.1 |
| GEHC R&D Life Sci | NA | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Res Tomsk Polytech Univ | University | Russian Federation | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Sechenov Univ | University | Russian Federation | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Syncom B.V. | Company | Netherlands | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Syncom BV | Company | Netherlands | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Bar-Ilan University | University | Israel | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Capio AB | Other health services | Sweden | 1 | 0 | 1 | 0 | 0 | 0.1 |
| NICPB | Institute | Estonia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Smithsonian Institution | Other Public | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Turku PET Centre | Institute | Finland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Basel | University | Switzerland | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Oxford | University | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Evox Therapeutics | Company | United Kingdom | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Monash University | University | Australia | 1 | 0 | 1 | 0 | 0 | 0.1 |
| TERI | NA | India | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Duisburg-Essen | University | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Washington University in St. Louis | University | United States | 1 | 0 | 1 | 0 | 0 | 0.1 |
| European Molecular Biology Laboratory (EMBL) | Other Public | Germany | 1 | 0 | 1 | 0 | 0 | 0.1 |
| French National Centre for Scientific Research | Other Public | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Grenoble Alpes University | University | France | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Université Catholique de Louvain | University | Belgium | 1 | 0 | 1 | 0 | 0 | 0.1 |
| University of Udine | University | Italy | 1 | 0 | 1 | 0 | 0 | 0.1 |
| Publication Year | Publications | Open Access publications | OA gold | OA hybrid | OA green | OA bronze | Not OA | Share OA |
|---|---|---|---|---|---|---|---|---|
| 2014 | 19 | 13 | 7 | 1 | 3 | 2 | 6 | 68.4% |
| 2015 | 10 | 4 | 1 | 1 | 1 | 1 | 6 | 40.0% |
| 2016 | 19 | 13 | 6 | 3 | 1 | 3 | 6 | 68.4% |
| 2017 | 16 | 9 | 6 | 1 | 0 | 2 | 7 | 56.2% |
| 2018 | 17 | 10 | 6 | 3 | 0 | 1 | 7 | 58.8% |
| 2019 | 24 | 21 | 11 | 6 | 1 | 3 | 3 | 87.5% |
| 2020 | 16 | 15 | 9 | 5 | 1 | 0 | 1 | 93.8% |
| Total | 121 | 85 | 46 | 20 | 7 | 12 | 36 | 70.2% |
The Open Access type of the publications was fetched from the Unpaywall REST API. The method to determine the OA type is presented here.
In summary, the different OA types can be described as follows:
Gold: The full text has been found on a publisher website, in a journal that is fully OA.
Hybrid: The full text has been found on a publisher website, in a journal that is not fully OA.
Green: The full text has been found in an institutional repository, such as DiVA.
Bronze: The full text has been found on a publisher website but no OA license could be identified.
N.B.: This table is based on peer-reviewed publications for which Unpaywall could determine the OA type (necessary condition: have a DOI number). Unpaywall’s method is empirical and does not strictly equate to copyright license. As a consequence, the OA status of a given publication may vary with time — for example turning from “Not OA” to “Green” when a full text is added to DiVA.
| Publication Year | Publications | Total Citations | Average Citations | Uncited publications | Share uncited |
|---|---|---|---|---|---|
| 2014 | 4.9 | 58.3 | 11.9 | 0.0 | 0.0% |
| 2015 | 3.0 | 36.0 | 11.9 | 0.0 | 0.0% |
| 2016 | 3.5 | 49.6 | 14.1 | 0.0 | 0.0% |
| 2017 | 4.8 | 101.1 | 21.0 | 0.0 | 0.0% |
| 2018 | 2.6 | 17.5 | 6.6 | 0.0 | 0.0% |
| 2019 | 5.5 | 26.8 | 4.9 | 0.4 | 6.7% |
| 2020 | 3.9 | 5.4 | 1.4 | 0.7 | 18.3% |
| Total | 28.3 | 294.8 | 10.4 | 1.1 | 3.8% |
| Publication years | Publications | Average FWCI | Top 10% publications | Share Top 10% |
|---|---|---|---|---|
| 2014-2016 | 11.5 | 0.71 | 0.0 | 0.0% |
| 2015-2017 | 11.4 | 0.76 | 0.0 | 0.0% |
| 2016-2018 | 11.0 | 0.81 | 0.1 | 1.1% |
| 2017-2019 | 12.6 | 0.71 | 0.1 | 1.0% |
| Total | 24.1 | 0.71 | 0.1 | 0.5% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 42 (full counted) publications with good Web of Science coverage (at least 76.5%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
| Publication years | Publications | Average SNIP | Publications in Top 20% journals | Share Top 20% journals |
|---|---|---|---|---|
| 2014-2016 | 11.5 | 1.19 | 4.6 | 39.9% |
| 2015-2017 | 11.4 | 1.18 | 4.2 | 37.2% |
| 2016-2018 | 11.0 | 1.27 | 5.2 | 47.2% |
| 2017-2019 | 12.8 | 1.28 | 6.3 | 49.2% |
| 2018-2020 | 11.9 | 1.31 | 7.7 | 64.7% |
| Total | 28.2 | 1.25 | 13.8 | 49.1% |
| Publication years | Publications | Corporate co-publications | Share corporate | International co-publications | Share international |
|---|---|---|---|---|---|
| 2014-2016 | 48 | 3 | 6.2% | 11 | 22.9% |
| 2015-2017 | 43 | 3 | 7.0% | 12 | 27.9% |
| 2016-2018 | 48 | 2 | 4.2% | 15 | 31.2% |
| 2017-2019 | 52 | 1 | 1.9% | 16 | 30.8% |
| 2018-2020 | 52 | 1 | 1.9% | 22 | 42.3% |
| Total | 115 | 4 | 3.5% | 38 | 33.0% |
This table is based on Scopus publication types Article, Review and Conference Paper.
Rows are based on at least 43 (full counted) publications with good Web of Science coverage (at least 80.7%).
(DiVA publication type Article, peer review)
Indicators based on < 50 publications are considered unreliable
